oxprenolol has been researched along with indoramin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Barritt, DW; Kettle, MA; Marshall, AJ | 1 |
1 trial(s) available for oxprenolol and indoramin
Article | Year |
---|---|
Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Topics: Bendroflumethiazide; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Indoles; Indoramin; Male; Oxprenolol; Sleep Wake Disorders | 1980 |
2 other study(ies) available for oxprenolol and indoramin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |